23 julio 2009
Zalypsis Inicia Fase II Utero / Endometrio en EEUU , lo lleva Pharma Mar y Bradley J Monk ( el mismo del OVA 301 del Yondelis ) .
PD : Es mucha la relacion de este Farmaco con Yondelis ...
...
Estimated Enrollment: 62
Study Start Date: July 2009
Estimated Study Completion Date: April 2012
Estimated Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Locations
United States, California
Chao Family Comprehensive Cancer Center
Orange, California, United States, 92868
United States, Florida
Sylvester Comprehensive Cancer Center. University of Miami Miller School of Medicine
Miami, Florida, United States, 33136
United States, Massachusetts
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States, 02114-2617
United States, New Mexico
UNM (University of New Mexico) Cancer Center
Albuquerque, New Mexico, United States, 87131
United States, New York
Montefiore Medical Center
NY, New York, United States, 10461
United States, Oklahoma
OU Cancer Institute
Oklahoma, Oklahoma, United States, 73104
United States, Pennsylvania
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States, 19111-2497
Magee-Womens Hospital of UPMC
Pittsburgh, Pennsylvania, United States, 15213
United States, Texas
M.D. Anderson Cancer Center
Houston, Texas, United States, 77030
Sponsors and Collaborators
PharmaMar
Investigators
Principal Investigator: Bradley J Monk, M.D. Chao Family Comprehensive Cancer Center